ArticlebioRxiv : the preprint server for biology2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.
Wen-Hsuan Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.